Polaris Innovation Fund
Boston, Massachusetts, United StatesFounded 2017
The Polaris Innovation Fund, managed by Polaris Partners, aims to accelerate the commercial and therapeutic potential of early-stage academic research, focusing on healthcare, biopharma, and life sciences.
50% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $86.5M (across 5 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| SSatellite Bio | Series A | $110M | Apr 2022 |
| SSatellite Bio | Seed | $110M | Apr 2022 |
 Delphia Therapeutics | Series A | $67M | — |
| SSatellite Bio | Growth | $110M | — |
| LLarkspur | Unknown | $35.5M | — |
 Montis Biosciences | Seed | — | — |
Top Co-Investors
Polaris Partners4 shared
Catalio Capital Management3 shared
Lightspeed Venture Partners2 shared
Alexandria Venture Investments1 shared
GV1 shared
Alphabet Inc.1 shared
Nextech Invest Ltd.1 shared
aMoon1 shared
3E Bioventures Capital1 shared
Med-Fine Capital1 shared
Takeda Ventures, Inc.1 shared
Pfizer Ventures1 shared
Last updated: 20 October 2026